Pandith, A. A., Qasim, I., Zahoor, W., Shah, P., Bhat, A. R., Sanadhya, D., . . . Naikoo, N. A. (2018). Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide). Nature Portfolio.
Cita Chicago Style (17a ed.)Pandith, Arshad A., Iqbal Qasim, Wani Zahoor, Parveen Shah, Abdul R. Bhat, Dheera Sanadhya, Zafar A. Shah, y Niyaz A. Naikoo. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.
Cita MLA (8a ed.)Pandith, Arshad A., et al. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.